Table 3.
Age at the time of ICD implantation (years) | n | Events/100 person-years (no. of events) | Unadjusted models |
Multivariable-adjusted modelsa |
||
---|---|---|---|---|---|---|
Hazard ratiob (95% CI) | P-value | Hazard ratiob (95% CI) | P-value | |||
Cardiac mortality | ||||||
<65 | 248 | 1.8 (19) | Reference group | — | Reference group | — |
65–75 | 135 | 4.7 (25) | 2.6 (1.5–4.8) | 0.001 | 3.1 (1.6–6.1) | 0.001 |
>75 | 119 | 7.3 (27) | 4.1 (2.3–7.4) | <0.001 | 4.1 (2.1–8.0) | <0.001 |
Non-cardiac mortality | ||||||
<65 | 248 | 0.9 (10) | Reference group | — | Reference group | — |
65–75 | 135 | 1.9 (10) | 2.0 (0.8–4.9) | 0.11 | 1.9 (0.7–5.1) | 0.22 |
>75 | 119 | 4.9 (18) | 5.3 (2.5–11.6) | <0.001 | 5.1 (2.0–12.8) | <0.001 |
CI, confidence interval.
aAdjusted for sex, prior sudden cardiac death, ICD implantation indication, history of congestive heart failure, left ventricular ejection fraction≤35%, ischaemic cardiomyopathy diagnosis, prior coronary revascularization, renal disease, stroke, hypertension, dyslipidaemia, history of cigarette smoking, history of malignancy, diabetes mellitus, and chronic obstructive pulmonary disease.
bUsing Wald tests to assess the overall associations, age was strongly associated with cardiac mortality in unadjusted (P < 0.001) and adjusted models (P < 0.001) and non-cardiac mortality in unadjusted (P < 0.001) and adjusted models (P = 0.001).